Frederick T Murphy DO FACP,FACR
Adjunct Clinical Assistant Professor of Medicine University of Pennsylvania 2001-2014
Join to View Full Profile
175 Meadowbrook LnDuncansville, PA 16635
Phone+1 814-693-0300
Dr. Murphy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumFellowship, 1996 - 1998- National Capital ConsortiumResidency, 1993 - 1996
Philadelphia College of Osteopathic MedicineClass of 1993
Certifications & Licensure
PA State License 2000 - 2026
VA State License 1996 - 2000
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Patients Choice Award 2009
Clinical Trials
- Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis Start of enrollment: 2002 Sep 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsEfficacy and Safety of Intravenous Golimumab Through One Year in Patients With Active Psoriatic Arthritis.M. Elaine Husni, Arthur Kavanaugh, Frederick T Murphy, Dmytro Rekalov, Diane D. Harrison
Arthritis Care & Research. 2020-06-01 - 43 citationsGolimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the mult...Josef S Smolen, Jonathan Kay, Mittie K. Doyle, Robert Landewé, Eric L. Matteson
Arthritis Research & Therapy. 2015-01-22 - 28 citationsEfficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.Lynn R. Webster, John F. Peppin, Frederick T. Murphy, Biao Lu, Jeffrey Tobias
Diabetes Research and Clinical Practice. 2011-08-01
Professional Memberships
- Fellow
- Fellow
External Links
- enspice children’s foundation http://www.enspice.org
- enspicehttp://www.enspice.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
